• Users Online: 484
  • Print this page
  • Email this page
This article has been cited by
1Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019
Rolf Teschke
Frontiers in Pharmacology.2019;10()
[DOI]
2Cefepime/ceftazidime/teicoplanin
Rolf Teschke
Reactions Weekly.2019;1750(1)74
[DOI]
3Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis
Rolf Teschke,Gaby Danan
Medicines.2020;7(10)62
[DOI]
4Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis
Rebecca A. Buckler,Meghan T. Mitchell,Samantha R. Phillips
Medicines.2020;42(10)253
[DOI]